Visum Pharmaceutica is a integrated pharmaceutical company specialized in R&D, manufacturing and export of high-technical oriented oral solid pharmaceutical preparations, and is committed to building a high-class international one-stop CDMO platform, providing various customization services for global customers who marketed in China, U.S., EU and WHO etc. The company has been taken 4 GMP inspections by U.S. FDA and 4 quanlity inspections by Chinese NMPA, allowing 5 products marketed in China and U.S. at present. It has reached 500 million tablets export quantity in last two years for its Metoprolol Succinate Extended-Release Tablets product.
Year Established: 2010
Total Number of Staff: 100-500
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Quality Service
Business Type: Service Provider,Manufacturer
R&D Capacity: OEM,ODM,Own Brand
Main Sales Markets : North America,Asia
Subscribe to the latest newsletter of Virtual Expo Connect